abstract |
Provided herein are methods of making, purifying and formulating antibody drug conjugates (ADCs). These methods use continuous bonding processes, single-pass tangential flow filtration, countercurrent diafiltration, and/or in-line process automation techniques. This method reduces process time and cost and improves product consistency. |